LifePoint Hospitals Inc. (LPNT) Stock Price Down 1.8%
Shares of LifePoint Hospitals Inc. (NASDAQ:LPNT) dropped 1.8% during trading on Thursday . The stock traded as low as $65.49 and last traded at $65.51, with a volume of 125,589 shares changing hands. The stock had previously closed at $66.71.
LPNT has been the subject of several analyst reports. Credit Suisse Group AG reiterated a “buy” rating on shares of LifePoint Hospitals in a report on Tuesday, June 28th. Citigroup Inc. increased their target price on shares of LifePoint Hospitals from $75.00 to $82.00 and gave the company a “buy” rating in a report on Monday, June 6th. Sterne Agee CRT reiterated a “buy” rating on shares of LifePoint Hospitals in a report on Monday, May 16th. Robert W. Baird reiterated a “buy” rating on shares of LifePoint Hospitals in a report on Monday, May 16th. Finally, Leerink Swann reiterated a “hold” rating on shares of LifePoint Hospitals in a report on Monday, May 2nd. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the stock. LifePoint Hospitals currently has a consensus rating of “Hold” and a consensus price target of $75.78.
The stock has a market capitalization of $2.85 billion and a P/E ratio of 18.19. The company’s 50-day moving average price is $66.58 and its 200-day moving average price is $67.46.
LifePoint Hospitals (NASDAQ:LPNT) last posted its earnings results on Friday, April 29th. The company reported $0.87 EPS for the quarter, missing analysts’ consensus estimates of $0.88 by $0.01. The firm earned $1.58 billion during the quarter, compared to analysts’ expectations of $1.57 billion. The business’s revenue was up 25.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.00 EPS. Equities research analysts predict that LifePoint Hospitals Inc. will post $3.74 EPS for the current fiscal year.
In other news, Director John E. D. D S. Maupin, Jr. sold 3,800 shares of the stock in a transaction that occurred on Wednesday, May 25th. The stock was sold at an average price of $67.32, for a total transaction of $255,816.00. Following the completion of the transaction, the director now directly owns 22,813 shares in the company, valued at approximately $1,535,771.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
A number of hedge funds recently modified their holdings of the company. Sei Investments Co. increased its stake in shares of LifePoint Hospitals by 123.0% in the fourth quarter. Sei Investments Co. now owns 24,386 shares of the company’s stock worth $1,790,000 after buying an additional 13,453 shares in the last quarter. BOKF NA increased its stake in shares of LifePoint Hospitals by 4.2% in the fourth quarter. BOKF NA now owns 27,886 shares of the company’s stock worth $2,047,000 after buying an additional 1,121 shares in the last quarter. Liberty Mutual Group Asset Management Inc. increased its stake in shares of LifePoint Hospitals by 51.4% in the fourth quarter. Liberty Mutual Group Asset Management Inc. now owns 28,627 shares of the company’s stock worth $2,101,000 after buying an additional 9,720 shares in the last quarter. Deere & Co. increased its stake in shares of LifePoint Hospitals by 15.5% in the fourth quarter. Deere & Co. now owns 29,316 shares of the company’s stock worth $2,152,000 after buying an additional 3,940 shares in the last quarter. Finally, Shell Asset Management Co. bought a new stake in shares of LifePoint Hospitals during the fourth quarter worth about $2,293,000.
LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.